News for Healthier Living

First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington's disease clinical trial REGEN4HD

* Huntington's disease is a genetic disorder that gradually destroys brain cells over the course of 10 to 30 years, typically starting between the ages of 35 and 50 * Phase 1b/2a will evaluate the safety of the treatment and provides hope for those with few options to slow the progression of the disease * Clinical trial will enroll 21 people with early-stage Huntington's disease, with 12 participants in a phase 1b dose-escalation group and nine in a phase 2a expansion group

June 23, 2026


July 3 2026

July 2 2026

July 1 2026

June 30 2026

June 29 2026

June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026